Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Isidori

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|September 17, 2004
Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?Giuseppe Visani, Michele Malagola, Pier Paolo Piccaluga, et al.
Frontiers in Oncology|October 24, 2022
Treatment options for acute myeloid leukemia patients aged <60 yearsGiuseppe Visani, Martina Chiarucci, Sara Paolasini, et al.
Frontiers in Oncology|September 28, 2020
Caring for AML Patients During the COVID-19 Crisis: An American and Italian ExperienceLindsay Wilde, Alessandro Isidori, Gina Keiffer, et al.
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Frontiers in Oncology|October 16, 2019
BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid LeukemiaFederica Loscocco, Giuseppe Visani, Sara Galimberti, et al.
Frontiers in Oncology|September 14, 2020
Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be LearnedAlessandro Isidori, Laurence de Leval, Usama Gergis, et al.
Haematologica|January 12, 2005
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patientsAlessandro Isidori, Francesca Bonifazi, Giuseppe Visani, et al.
Frontiers in Oncology|September 23, 2021
Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant RecipientsMartina Chiarucci, Sara Paolasini, Alessandro Isidori, et al.
Frontiers in Oncology|October 26, 2019
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid LeukemiaDarina Ocadlikova, Mariangela Lecciso, Alessandro Isidori, et al.
World Journal of Stem Cells|September 2, 2015
Advancement in high dose therapy and autologous stem cell rescue in lymphomaAlessandro Isidori, Cristina Clissa, Federica Loscocco, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|September 17, 2004
Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?Giuseppe Visani, Michele Malagola, Pier Paolo Piccaluga, et al.
Frontiers in Oncology|October 24, 2022
Treatment options for acute myeloid leukemia patients aged <60 yearsGiuseppe Visani, Martina Chiarucci, Sara Paolasini, et al.
Frontiers in Oncology|September 28, 2020
Caring for AML Patients During the COVID-19 Crisis: An American and Italian ExperienceLindsay Wilde, Alessandro Isidori, Gina Keiffer, et al.
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Frontiers in Oncology|October 16, 2019
BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid LeukemiaFederica Loscocco, Giuseppe Visani, Sara Galimberti, et al.
Frontiers in Oncology|September 14, 2020
Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be LearnedAlessandro Isidori, Laurence de Leval, Usama Gergis, et al.
Haematologica|January 12, 2005
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patientsAlessandro Isidori, Francesca Bonifazi, Giuseppe Visani, et al.
Frontiers in Oncology|September 23, 2021
Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant RecipientsMartina Chiarucci, Sara Paolasini, Alessandro Isidori, et al.
Frontiers in Oncology|October 26, 2019
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid LeukemiaDarina Ocadlikova, Mariangela Lecciso, Alessandro Isidori, et al.
World Journal of Stem Cells|September 2, 2015
Advancement in high dose therapy and autologous stem cell rescue in lymphomaAlessandro Isidori, Cristina Clissa, Federica Loscocco, et al.
Pageof 9